G-Series Grind Guard
ASESSO HEALTH, Inc. · Decision date Jun 25, 2026
What did the FDA decide?
FDA records K260790 as a 510(k) premarket notification, with a decision dated Jun 25, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Jun 25, 2026
Regulatory record facts
- Identifier
- K260790
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ASESSO HEALTH, Inc.
- Product code
- OBR
- Decision code
- SESE
- Decision date
- Jun 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Mouthguard, Over-The-Counter.
- Applicant
- ASESSO HEALTH, Inc.
- Product code
- OBR
- FDA device class
- U
FDA decision timeline
K260790 received
Application receipt date recorded by FDA.
K260790 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OBR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Mouth guardK262280 | Dongguan Yiyao Science & Technology Development Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA |
Mouth GuardK262559 | ChangSha ChuangDuoLe E-Commerce Co., Ltd. | 510(k) clearance | Sep 16, 2026 | FDA |
| 1987 Media Limited | 510(k) clearance | Apr 10, 2026 | FDA | |
Owl Night GuardK253641 | Owl Dental Lab, Inc. | 510(k) clearance | Feb 26, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ASESSO HEALTH, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Pleasanton, CA
Sources and methodology
- Original FDA record: K260790
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

